AstraZeneca product withdrawn

At the end of April AstraZeneca admitted in court that its product could cause clots that could kill. A proportion of the claimants who were vaccinated after the 7th April were asked by the legal team to withdraw from the case because at that point AstraZeneca added a line into their patient information leaflet to include a rare risk of clots as an adverse event.

Read More

Too high a bar for drug safety calls

Drug safety regulation appears to be a lone wolf in the world of safety regulation. The aviation sector doesn’t ignore safety incidents “because they are outweighed by the benefits” and nor should the drug regulators. The aviation baseline is “less than 1 fatal accident per 1 million flying hours”. The alarm bells ring as soon as there is 1 fatal accident. Actually, even a near-miss gets them excited.

Read More

Gender ideology: What’s happening in the rest of the UK?

Gender ideology has been topical in England in recent years, with significant happenings, such as The Gender Identity Development Service (GIDS) at the Tavistock Clinic closing, the banning of puberty blockers being prescribed to children, and the release of the recent CASS report, which highlighted the lack of a clear evidence base for allowing children to change sex. In a further shift of policy, NHS England has rightly stated that biological sex is fact and should be respected in hospital settings.

Read More

HART Ethics

Several members of HART are authors of a new pre-print on ethics. It takes an in-depth look at the historical and ethical framework that has guided medical practices for centuries—from the Hippocratic Oath to modern legal standards like the Nuremberg Code and the Declaration of Helsinki.

Read More

Then and Now

The account below was sent in to us by a HART follower who works in a busy A&E department, comparing the workload and the treatment options in the spring of 2020 with that of 2024. Here we reproduce it in full, with some added links to previous HART articles.

Read More

Conflicts in Cancer Data

Many of our readers will be aware of the claims of a rise in cancers since the vaccine rollout, particularly among the young. Last week we published an article discussing the scientific rationale why a rise in cancers might be expected after the vaccine rollout. The data published by the UK on this topic is contradictory but data from around the world is signifying there is a genuine problem.

Read More

Covid-19 Response and Excess Deaths

On 18th April, Andrew Bridgen finally secured a full length debate on this vexed topic, the original text of which is available here. Full length in theory, but shortly before the debate was due to begin, the deputy Speaker told him he only had 15 minutes instead of the 30 minutes he had prepared. After a complaint to the Speaker’s office the compromise was 20 minutes.

Read More

Book Review – Will Ellsworth-Jones’ We Will Not Fight (2008)

Like with so much history that is shrouded by the mists of time, the detailed tales of the thousands of British men who refused to fight in the First World War make for fascinating reading.  These conscientious objectors came from all walks of life – socialists, communists, pacifists, Quakers, Jehovah’s witnesses, Methodists, the Bloomsbury Set – and found a unity of purpose in their protest, allowing them – for a time being at least – to put aside quite substantial ideological differences.  

Read More

Have people died from ‘long covid’?

The deniers of vaccine harm have only two ways of addressing the excess death problem. They either deny that it exists or try to blame it on covid or ‘long covid’. HART have previously addressed why covid is not an adequate explanation for the problem because the timing of the non-covid excess has been synchronous in places that had no significant covid until 2022.

Read More

Cancer concerns

The covid vaccines skipped safety testing for cancer risk. Pfizer said genotoxicity, carcinogenicity and biodistribution studies were “not considered necessary.” Even while their trial info sheet said “Due to the urgent need for a vaccine against Covid-19, with agreement from the MHRA, some of the tests usually required for a newly manufactured vaccine have been modified, in order to make the vaccine available more quickly for assessment.”

Read More